[HIVR4P2024] Lima, Peru -- New data from the PURPOSE 2 study of twice-yearly lenacapavir for HIV prevention are among the scientific highlights at HIVR4P 2024, the 5th HIV Research for Prevention Conference, taking place in Lima, Peru, and virtually from 6 to 10 October.